TTrialPathMatch Me to Trials
← Back to trials
RecruitingPeripheral Artery DiseaseIntermittent ClaudicationPeripheral Vascular Disease

Improving Mobility After Revascularization in Peripheral Artery Disease

Eligible age

18+ yrs

Accepts

All genders

Locations

7 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Lower extremity revascularization combined with supervised exercise significantly improves walking performance compared to revascularization alone in people who have PAD without limb threatening ischemia. However, supervised exercise is inaccessible or burdensome for most PAD patients. Investigators hypothesize that home-based exercise combined with lower extremity revascularization will significantly improve walking performance compared to revascularization alone in patients with PAD undergoing revascularization for disabling PAD. Investigators further hypothesize that inorganic nitrate, a major source of nitric oxide (NO) abundant in beetroot juice, will improve walking performance after lower extremity revascularization, compared to placebo. In preclinical models, NO inhibits inflammation, neointimal hyperplasia, thrombosis, and vascular smooth muscle cell migration at sites of revascularization. NO increases angiogenesis and perfusion, repairs skeletal muscle damaged by ischemia, and stimulates mitochondrial activity. In a randomized clinical trial with a 2 x 2 factorial design, the trial will test the following two primary hypotheses in 386 patients randomized within three months of a successful lower extremity revascularization for disabling PAD: First, that home-based exercise combined with lower extremity revascularization will improve six-minute walk distance more than revascularization alone at 6-month follow-up (Primary Aim #1). Second, that nitrate-rich beetroot juice combined with lower extremity revascularization will improve six-minute walk, compared to placebo combined with revascularization at 6-month follow-up (Primary Aim #2).

Sponsor: Northwestern University

You may qualify if…

  • ✓ Successful lower extremity revascularization for disabling PAD performed at least 30 days before baseline testing and between 30 and 100 days before randomization.

You may not qualify if…

  • ✕ 1. History of leg amputation, not including toe and partial foot amputation
  • ✕ 2. Active gangrene
  • ✕ 3. Active limb threatening ischemia
  • ✕ 4. Already exercising at a level consistent with exercise intervention, using investigator discretion.
  • ✕ 5. Unstable angina
  • ✕ 6. Unwilling to drink study beverages
  • ✕ 7. Unwilling to adhere to the interventions and complete follow-up testing
  • ✕ 8. Currently taking sildenafil, tadalafil, or related drugs.

Where it's recruiting

Arizona

Tucson

Florida

Tampa

Georgia

Atlanta

Illinois

Chicago

Michigan

Detroit

Source: ClinicalTrials.gov · NCT06686121 · last updated 2026-10-05

Improving Mobility After Revascularization in Peripheral Artery Diseas · TrialPath